| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 355 | $11.66 | $4,137.88 | - | |
| Nov 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 97 | $7.81 | $757.57 | -0.1% | |
| Nov 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 371 | $7.82 | $2,899.40 | - | |
| Oct 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 350 | $10.13 | $3,544.80 | - | |
| Oct 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 91 | $10.14 | $923.10 | -0.1% | |
| Sep 16, 2020 | Moyes Jay M49 | Director | Sell | 9,703 | $10.00 | $97,030.00 | -23.5% | |
| Sep 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 90 | $9.77 | $879.30 | -0.1% | |
| Sep 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 347 | $9.78 | $3,393.35 | - | |
| Aug 3, 2020 | Bryce Richard Paul | See Remarks | Sell | 86 | $10.80 | $928.80 | -0.1% | |
| Aug 3, 2020 | Auerbach Alan H62 | President And CEO | Sell | 330 | $10.79 | $3,560.70 | - |